Onconetix shareholders approve reverse stock split (1:2 to 1:50) at special meeting

Onconetix, Inc.

• Reverse stock split proposal passed with 562,803 votes for, 123,144 against, 986 abstentions.
• Board authorized to implement split at any ratio between 1-for-2 and 1-for-50 on or before Feb 3, 2027.
• Adjournment proposal also approved with 567,357 votes for, 118,604 against, 972 abstentions.
• Total outstanding shares as of Dec 12, 2025 record date: 1,555,015 shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.